MET and neoplasm: Overexpression of HGF/SF, abnormal expression of c-Met, and mutation activation, and so on, can lead to abnormal activation of the c-Met signaling pathway, thereby promoting abnormal proliferation, growth, invasion, and diffusion of tumor cells (Zhang et al., 2020; Maria et al., 2019).